Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.

[1]  S. Nakanishi,et al.  Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Hökfelt,et al.  Intranigral substance P stimulation of striatal dopamine release is inhibited by Spantide II: a new tachykinin antagonist without apparent neurotoxicity , 1990, Brain Research.

[3]  Z. Wiesenfeld‐Hallin,et al.  The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in rat , 1990, Brain Research.

[4]  C. Maggi,et al.  Competitive antagonists discriminate between NK2 tachykinin receptor subtypes , 1990, British journal of pharmacology.

[5]  R. Håkanson,et al.  Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Quirion,et al.  Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord , 1990, Brain Research.

[7]  C. Maggi,et al.  A potent and selective agonist for NK-2 tachykinin receptor , 1989, Peptides.

[8]  P. Mantyh,et al.  Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  S. H. Buck,et al.  Agonist and antagonist binding to tachykinin peptide NK-2 receptors. , 1988, Life sciences.

[10]  R. Håkanson,et al.  Biological evaluation of substance P antagonists , 1984, British journal of pharmacology.

[11]  A. Saria,et al.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Sundler,et al.  A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation , 1981, Nature.